Some companies used genetic results to market expensive, unproven "personalized" supplements.
CAS 125079-83-6 refers to CU-CPT-8m , a chemical compound used in research as a Toll-like Receptor (TLR) antagonist. 125079
Investigators found instances of "egregious" marketing, where sales representatives made claims that the tests could "predict" diseases with a certainty that current science does not support. Why the Discrepancy? Some companies used genetic results to market expensive,
Vautier Pharmacy uses the ID 125079 for their "Get Ready for Winter" health guide. pSR300.3 (Plasmid #125079) - Addgene Why the Discrepancy
The 125079 report highlighted that while the sequencing of the DNA might be accurate, the interpretation was the Wild West. Different companies used different research studies to calculate risk, leading to the "genetic guessing" the GAO warned against. The Lasting Impact This report was a turning point that led to:
"125079" most prominently refers to a report regarding the marketing and accuracy of direct-to-consumer (DTC) genetic tests .